CVC Explores Options for €11 Billion Drugmaker Recordati
CVC Capital Partners is exploring options for its controlling stake in Italian drugmaker Recordati SpA, according to people familiar with the matter.
CVC Capital Partners is exploring options for its controlling stake in Italian drugmaker Recordati SpA, according to people familiar with the matter.
Allfunds Group Plc has abandoned discussions over a potential sale of the European fund distribution platform, people with knowledge of the matter said.
Temenos AG, the financial software company targeted by a short seller report earlier this year, announced its new chief executive officer after repeated activist calls to replace interim CEO Andreas Andreades.
Kering SA shares tumbled after the luxury group warned that profit will plunge in the first half of the year on slumping sales at Gucci, its biggest brand.
The European Central Bank can’t commit to what will happen after a likely first reduction in borrowing costs in June, according to Governing Council member Joachim Nagel.
{{ video.ContentPackages[0].ScheduleStartDateTime | fromNow }}
{{ currentStream.Desc }}